SMS Pharmaceuticals Ltd has informed BSE that in terms of Companys "Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information" to regulate, monitor and report Insider Trading and in accordance with Regulation 9 of SEBI (Prohibition of Insider Trading) Regulations, 2015 along with Clause 36 of the Listing Agreement entered with the Stock Exchanges, the Trading Window of the Company will remain closed from November 05, 2015 to November 10, 2015 (both days inclusive) for consideration and declaration of Un-audited Financial Results for the quarter ended September 30, 2015 at the Meeting of the Board of Directors of the Company Schedule to be held on November 07, 2015.
Source : BSE - >www.bseindia.com
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.